Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway. The gene discussed is OPRK1; the disease is obesity due to melanocortin 4 receptor deficiency.